Do you discontinue eplerenone in patients with hypertension who believe the medication may be resulting in gynecomastia?

Unlike spironolactone, gynecomastia due to eplerenone is uncommon since eplerenone is a selective mineralocorticoid receptor antagonist with substantially less androgen and progesterone receptor activity than spironolactone. Therefore, one should confirm that the patient has true glandular gynecomas...